IDG, Qiming co-lead $70m Series B funding in biotech firm ZhenGe

IDG, Qiming co-lead $70m Series B funding in biotech firm ZhenGe

Contract development and manufacturing organisation (CDMO) firm Shanghai ZhenGe Biotechnology Co., Ltd has secured as much as $70 million in its Series B round of financing jointly led by China’s global VC Qiming Venture Partners and return backer IDG Capital.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter